Poonam Sahu

Ms. Poonam Sahu


Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications

1 January 2025 in Advances in Biomarker Sciences and Technology
Verified
Journal Article
Open access
TSTrilochan Satapathy
Trilochan Satapathy
NPNikita Patel
Nikita Patel
PSPoonam Sahu
Poonam Sahu
ASAbhisek Satapathy
Abhisek Satapathy

1 February 2026 in Current Drug Metabolism
Verified
Journal Article
Closed access
PDF file
PSPoonam Sahu
Poonam Sahu
TSTrilochan Satapathy
Trilochan Satapathy
Introduction: This review aims to explore the therapeutic potential and safety of herbal bi-oactive compounds in the treatment of various liver disorders. As the liver plays a critical role in diges-tion, detoxification, energy storage, and protein synthesis, any impairment in its function can lead to significant health complications. The study aims to identify effective herbal agents that may support liver health. Methods: A comprehensive literature search was conducted using scientific databases and platforms including Web of Science, Scopus, PubMed, HINARI, ScienceDirect, and Google Scholar. The review includes studies that investigate the hepatoprotective potential of herbal bioactives, while research re-lated to hepatic cancers was excluded to maintain a focus on non-malignant liver disorders. Results: The review identifies several medicinal plants and their active constituents that exhibit hepa-toprotective properties. These bioactives function through various pharmacological mechanisms at the molecular level. Common liver conditions addressed include fatty liver, hepatitis, fibrosis, steatosis, and cirrhosis. The reviewed compounds demonstrate antioxidant, anti-inflammatory, and antifibrotic activities, supporting their role in liver disease management. Discussion: The findings support growing evidence that herbal bioactives can modulate key molecular pathways involved in liver disorders. These results align with existing studies highlighting the benefits of plant-based treatments. However, the limitations include a lack of clinical trial data, poor bioavaila-bility of some compounds, and the need for standardized formulations. Further research is necessary to validate these results in human populations. Conclusion: Herbal bioactives such as flavonoids, polyphenols, alkaloids, glycosides, saponins, vita-mins, and essential oils show promising hepatoprotective effects. This review emphasizes the im-portance of understanding their precise molecular mechanisms and ADME (absorption, distribution, metabolism, and excretion) profiles. These insights are crucial for developing safe, effective, and stand-ardized herbal therapies for liver disease management.

1 December 2025 in Letters in Drug Design & Discovery
Verified
Journal Article
Open access
PSPoonam Sahu
Poonam Sahu
ASAbinash Satapathy
Abinash Satapathy
ASAbhisek Satapathy
Abhisek Satapathy
TSTrilochan Satapathy
Trilochan Satapathy

17 March 2026 in Archives of Microbiology
Verified
Journal Article
Closed access
PDF file
PSPoonam Sahu
Poonam Sahu
TSTrilochan Satapathy
Trilochan Satapathy

15 November 2025 in Journal of Drug Delivery and Therapeutics
Verified
Journal Article
Open access
PDF file
TSTrilochan Satapathy
Trilochan Satapathy
PSPoonam Sahu
Poonam Sahu
ASAbhisek Satapathy
Abhisek Satapathy
SBShiv Kumar Bhardwaj
Shiv Kumar Bhardwaj
ASAbinash Satapathy
Abinash Satapathy
MCManisha Chandrakar
Manisha Chandrakar
Nipah virus (NiV), a highly pathogenic member of the Henipavirus genus within the Paramyxoviridae family, continues to represent a critical zoonotic threat at the intersection of humans, animals, and the environment. First identified in Malaysia in 1998, NiV has since emerged as a paradigm of viral spillover driven by ecological disruption and anthropogenic activities. This review elucidates contemporary insights into the complex interplay governing NiV transmission dynamics, molecular neurotropism, and its potential to precipitate future pandemics. The spillover of NiV from its natural reservoir, Pteropus fruit bats, to intermediate hosts such as pigs, and ultimately to humans, is profoundly influenced by habitat fragmentation, agricultural intensification, and climate-induced alterations in bat foraging behavior. At the molecular level, NiV exhibits pronounced neurotropism and vasculotropism mediated through its interaction with ephrin-B2 and ephrin-B3 receptors, leading to widespread endothelial infection, microvascular damage, and neuronal dysfunction that culminate in fatal encephalitis. Moreover, the virus demonstrates immune evasion strategies that suppress interferon signaling, thereby facilitating systemic dissemination. Despite its high case fatality rate and recurrent outbreaks in South and Southeast Asia, the absence of licensed antiviral therapies or vaccines underscores the urgency of advancing translational research and cross-sectoral surveillance frameworks. The convergence of ecological perturbations, viral adaptability, and limited healthcare infrastructure in endemic regions amplifies the likelihood of future spillover and sustained human-to-human transmission. A unified One Health approach integrating virological, ecological, and epidemiological disciplines is imperative to mitigate NiV’s pandemic potential and to strengthen global preparedness against emerging zoonoses. Keywords: Neurotropism, Nipah virus (NiV), One Health, Pandemic preparedness, Spillover dynamics, Zoonotic transmission.